What happens to the pleural space affected by malignant effusion after bedside pleurodesis?

被引:2
|
作者
de Araujo, Pedro H. X. N. [1 ]
Terra, Ricardo M. [1 ]
Santos, Thiago da Silva [1 ]
Chate, Rodrigo C. [2 ]
de Paiva, Antonio F. L. [2 ]
Pego-Fernandes, Paulo M. [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Hosp Clin, Thorac Surg Div, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Sch Med, Hosp Clin, Div Radiol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
CT scan; neoplasm; pleural disease; radiology and other imaging; thoracic surgery; TALC PLEURODESIS; POUDRAGE; CT; MANOMETRY; PRESSURE;
D O I
10.1002/jso.25040
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and objectivesEvaluate radiological characteristics of postpleurodesis pleural space of patients with recurrent malignant pleural effusion(RMPE). MethodsProspective cohort study including patients with RPME treated with bedside pleurodesis. We used CT scans to calculate pleural cavity volume immediately before pleurodesis(iCT) and 30 days after(CT30). Radiological evolution was calculated by the difference between pleural volumes on CT30 and iCT(volume). We categorized initial pleural volume as small(<500mL) or large space(500mL) and volume as positive(>254.49mL), unchanged(-268.77-254.49mL), or negative(<-268.77mL). Futhermore, we analyzed clinical effectiveness, pleural elastance, and adverse events. ResultsA total of 87 patients were analyzed. Pleural volume varied from 35-2750mL in iCT and from 0-2995mL in CT30(P=0.753). A total of 54 patients had initial small pleural space(62.06%) and 33 large(37.93%). Clinical failure occurred in 7.4% of small space group and in 24.6% of large(P=0.051, OR4.0(CI:1.098-14.570)). In small space group, 27.77% evolved with positive, 66.66% with unchanged and 5.55% with negative volume. In the large space group these numbers were respectively 21.21%, 27.27%, and 51.51%. ConclusionsThere is significant variability on pleural space volume. However, pleural volume remains unchanged in many cases. Besides that, more than half patients with initial large space coursed with relevant reduction. Finally, patients with initial small space presented a greater chance of clinical success.
引用
收藏
页码:1556 / 1562
页数:7
相关论文
共 50 条
  • [41] Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of randomized controlled trials
    Li Wang
    Huan Deng
    Xinling Chen
    Can Li
    Fengming Yi
    Yiping Wei
    Wenxiong Zhang
    World Journal of Surgical Oncology, 18
  • [42] Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial
    Keeratichananont, Warangkana
    Kaewdech, Apichat
    Keeratichananont, Suriya
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [43] Prognostic Factors for Survival after Surgical Palliation of Malignant Pleural Effusion
    Pilling, John E.
    Dusmet, Michael E.
    Ladas, George
    Goldstraw, Peter
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) : 1544 - 1550
  • [44] Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion
    Fitzgerald, Deirdre B.
    Sidhu, Calvin
    Budgeon, Charley
    Tan, Ai Ling
    Read, Catherine A.
    Kwan, Benjamin C. H.
    Smith, Nicola Ann
    Fysh, Edward T.
    Muruganandan, Sanjeevan
    Saghaie, Tajalli
    Shrestha, Ranjan
    Badiei, Arash
    Nguyen, Phan
    Burke, Andrew
    Goddard, John
    Windsor, Morgan
    McDonald, Julie
    Wright, Gavin
    Czarnecka, Kasia
    Sivakumar, Parthipan
    Yasufuku, Kazuhiro
    Feller-Kopman, David J.
    Maskell, Nick A.
    Murray, Kevin
    Lee, Y. C. Gary
    TRIALS, 2022, 23 (01)
  • [45] Malignant pleural effusion treatment outcomes: Pleurodesis via video-assisted thoracic surgery (VATS) versus tube thoracostomy
    Luh, S. -P.
    Chen, C. -Y.
    Tzao, C. -Y.
    THORACIC AND CARDIOVASCULAR SURGEON, 2006, 54 (05) : 332 - 336
  • [46] Pleural catheters after thoracoscopic treatment of malignant pleural effusion: a randomized comparative study on quality of life
    Petrella, Francesco
    Maisonneuve, Patrick
    Borri, Alessandro
    Casiraghi, Monica
    Donghi, Stefano
    Durkovic, Sava
    Filippi, Niccolo
    Galetta, Domenico
    Gasparri, Roberto
    Guarize, Juliana
    Lo Iacono, Giorgio
    Mariolo, Alessio Vincenzo
    Tessitore, Adele
    Spaggiari, Lorenzo
    JOURNAL OF THORACIC DISEASE, 2018, 10 (05) : 2999 - 3004
  • [47] Small-bore versus large-bore catheters for talc pleurodesis of malignant pleural effusion: a tertiary hospital experience
    Akturk, Ulku Aka
    Kocak, Nagihan Durmus
    Ozturk, Cansel Atinkaya
    Sengul, Aysun
    Ernam, Dilek
    Tepetam, Merve Alan
    Ersoz, Elcin
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (18): : 8001 - 8006
  • [48] Comparison of Efficacy and Safety of Talc to Povidone-Iodine Pleurodesis in Malignant Pleural Effusion: A Systematic Review and Meta-Analysis
    Balan, Divya
    Baral, Tejaswini
    Manu, Mohan K.
    Mohapatra, Aswini Kumar
    Miraj, Sonal Sekhar
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2025, 46 (01) : 24 - 30
  • [49] Mortality after treatment of malignant pleural effusions with indwelling pleural catheters versus chemical pleurodesis: a population-based study
    Kwok, Chanel
    Thavorn, Kednapa
    Amjadi, Kayvan
    Aaron, Shawn D.
    Kendzerska, Tetyana
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [50] Efficacy of medical thoracoscopic talc pleurodesis in malignant pleural effusion caused by different types of tumors and different pathological classifications of lung cancer
    Chen, Juan
    Li, Zhu
    Xu, Ning
    Zhang, Xin
    Wang, Yu
    Lin, Dianjie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 18945 - 18953